Failed 2023
Cue Health
Building a business on pandemic demand without a diversification plan is existential risk.
Founded → Closed
2010 → 2023
Funding Raised
$600M+
Industry
Healthcare/Diagnostics
Country
USA
IdeaProof AI Failure Score
65/100
Market Fit Risk
50
Burn Rate Risk
75
Founder Risk
25
Full Analysis
Cue Health built a molecular diagnostic testing device for COVID-19. Revenue collapsed from $481M in 2021 to a fraction as COVID testing demand evaporated. Cue filed for bankruptcy in 2023.
Could This Failure Have Been Prevented?
IdeaProof's AI validates market demand, competitive positioning, and business model viability in minutes — catching the exact issues that sank Cue Health.